EP3697386
LIQUID COMPOSITIONS FOR PERORAL USE COMPRISING PHOSPHATIDYLGLYCEROL DERIVATIVES AND THIXOTROPIC EXCIPIENTS FOR TREATING CARDIAC CHANNELOPATHIES CAUSED BY PHARMACOLOGICAL AGENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.10.2018EP published:
26.7.2023EP application number:
18868801.4
EPO information:
European Patent Register
Max expiry date:
18.10.2038
Title in English:
LIQUID COMPOSITIONS FOR PERORAL USE COMPRISING PHOSPHATIDYLGLYCEROL DERIVATIVES AND THIXOTROPIC EXCIPIENTS FOR TREATING CARDIAC CHANNELOPATHIES CAUSED BY PHARMACOLOGICAL AGENTSLanguage of the patent:
English
Timeline
Today
19.10.2018EP application
26.7.2023EP Publication
Owner
Name:
Signpath Pharma, Inc.Address:
9710 Ruskin Circle, Sandy, UT 84092, US
Inventor
Name:
HELSON, LawrenceAddress:
Quakertown PA 18951, US
Name:
SHOPP, George, M.Address:
Boulder CO 80302, US
Name:
BOUCHARD, AnnieAddress:
Stoke QC JOB 3GO, CA
Name:
MAJEED, MuhammedAddress:
East Windsor NJ 08520, US
Priority
Number:
201715788683Date:
19.10.2017Country:
US
Classification
Categories:
A61K 9/127, A61K 9/00, A61K 31/506, A61K 31/683, A61K 31/685, A61K 31/445, A61K 31/12, A61K 31/4545, A61P 9/00, A61P 9/02, A61P 9/04, A61P 9/06, A61P 35/00, A61P 37/08